Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001711279-23-000005
Filing Date
2023-02-02
Accepted
2023-02-02 17:01:17
Documents
4
Effectiveness Date
2023-02-02

Document Format Files

Seq Description Document Type Size
1 S-8 krysforms-8.htm S-8 68460
2 EX-FILING FEES exhibit107filingfeetablekr.htm EX-FILING FEES 13592
3 EX-5.1 exhibit51.htm EX-5.1 8423
4 EX-23.1 exhibit231.htm EX-23.1 2950
  Complete submission text file 0001711279-23-000005.txt   94427
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

EIN.: 821080209 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269539 | Film No.: 23582015
SIC: 2836 Biological Products, (No Diagnostic Substances)